Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional 5-fluorouracil for basal cell carcinoma
IRCT20240822062839N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil in basal cell carcinoma (BCC), sponsored by Mashhad University of Medical Sciences. Primary endpoint: BCC lesion complete regression. Started Sep 2024; status: completed.
02
Drugs
fluorouracil
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on IRCT20240822062839N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240822062839N1.